X0508 4 2024-08-01 false 0001831363 Terns Pharmaceuticals, Inc. TERN 0001799780 Quigley Jill M. C/O TERNS PHARMACEUTICALS, INC. 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 true false false false true Common Stock 2024-08-01 4 S false 6143.00 7.6751 D 23857.00 D Common Stock 2024-08-02 4 S false 8857.00 7.5005 D 15000.00 D Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person. This sale price represents the weighted average sale price of the shares sold ranging from $7.505 to $7.815 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024. This sale price represents the weighted average sale price of the shares sold ranging from $7.35 to $7.67 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ David Strauss as Attorney-in-Fact for Jill M. Quigley 2024-08-05